-
公开(公告)号:US20240075046A1
公开(公告)日:2024-03-07
申请号:US18259458
申请日:2021-12-27
Inventor: David Meiri , Vered Cohen
IPC: A61K31/00 , A61K31/135 , A61P15/00 , A61P35/00
CPC classification number: A61K31/658 , A61K31/135 , A61P15/00 , A61P35/00
Abstract: The present invention provides a pharmaceutical composition including one or more cannabinoids, and methods of using same, such as for treating estrogen receptor-related diseases. The present invention further provides combination therapy comprising one or more cannabinoids and an estrogen receptor activation inhibitor and use thereof in sensitizing subjects that are resistance to treatment with the estrogen receptor activation inhibitor alone.
-
公开(公告)号:US20230414639A1
公开(公告)日:2023-12-28
申请号:US18252715
申请日:2021-11-14
Inventor: David Meiri , Elazar Besser , Gil Moshe Lewitus , Paula Berman
CPC classification number: A61K31/658 , A61P17/06 , A61P35/00
Abstract: The present invention provides a pharmaceutical composition including one or more cannabinoids, and methods of using same, such as for treating NOTCH-related diseases.
-
公开(公告)号:US20230210796A1
公开(公告)日:2023-07-06
申请号:US18000392
申请日:2021-05-31
Inventor: David Meiri , Joshua Aviram
IPC: A61K31/192 , A61P25/06 , A61K45/06
CPC classification number: A61K31/192 , A61P25/06 , A61K45/06
Abstract: The present invention relates to pharmaceutical compositions containing certain phytocannabinoids and their use in treating or preventing headaches, particularly migraine headaches.
-
-